Keratoconjunctivitis, Infectious
Keratoconjunctivitis Sicca
Moraxella
Conjunctivitis, Viral
Conjunctiva
Moraxella (Moraxella) bovis
Adenovirus Infections, Human
Lacrimal Apparatus
Conjunctivitis
Mycoplasma conjunctivae
Ophthalmic Solutions
Adenoviruses, Human
Microsporidia
Sjogren's Syndrome
Shigella flexneri
Epidemics
Oxytetracycline
Rupicapra
Cornea
Shigella Vaccines
Fluorophotometry
Cromolyn Sodium
Fluorescein
Cattle Diseases
Administration, Topical
Corneal Ulcer
Sulfacetamide
Lissamine Green Dyes
Eye Infections, Viral
Disease Outbreaks
Mycoplasma
Fluorometholone
Arcanobacterium
Eosinophil Granule Proteins
Dysentery, Bacillary
Corneal Opacity
Conjunctival Diseases
Tuberculosis, Ocular
Dry Eye Syndromes
Experimental production of infectious bovine keratoconjunctivitis: comparison of serological and immunological responses using pili fractions of Moraxella bovis. (1/234)
The effect of vaccinating cattle and mice on the development of keratoconjunctivitis was studied. Cattle were vaccinated with whole cells, disrupted cells and pili fractions of three strains of Moraxella bovis. Mice were vaccinated with pili fractions of three strains. The resistance of all vaccinated animals was challenged with virulent cultures of M. bovis. In an attempt to correlate the response seen after vaccination and challenge with a pili fraction of M. bovis, vaccinated cattle and mice were grouped on the basis of signs of disease manifested and compared on the basis of serological responses. Serum samples were tested for antibodies by a gel diffusion precipitin test. A greater number of the sera of resistant cattle had antibodies to the homologous pili antigen than those of vaccinated nonresistant cattle. Cattle vaccinated with disrupted cells were not resistant to infectious bovine kerato-conjuctivitis and their sera lacked antibodies against the pili antigens. Vaccinated mice were more resistant to infectious bovine kerato-conjuctivitis and their sera lacked antibodies against the pili antigens. Vaccinated mice were more resistant to challenge exposure by homologous than heterologous cultures. A greater number of the sera of resistant mice had antibodies to pili antigens than nonresistant mice. (+info)Adaptive immune response to Shigella flexneri 2a cydC in immunocompetent mice and mice lacking immunoglobulin A. (2/234)
Shigella flexneri cydC, which is deficient in cytochrome bd, was rapidly cleared from the lungs of intranasally inoculated mice and was Sereny negative, yet it induced 93% protection against challenge with wild-type S. flexneri. Mice that lack immunoglobulin A (IgA) were fully protected, suggesting that IgA may not be required for adaptive immunity in this model system. (+info)Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. (3/234)
AIMS: To compare the efficacy of topical nedocromil 2% with fluorometholone 0.1% in vernal keratoconjunctivitis (VKC). METHODS: In a double masked random design, 24 patients with severe vernal keratoconjunctivitis were placed at random on nedocromil 2% eye drops in one eye and fluorometholone 0.1% in the fellow eye. At the end of the 2 week treatment period, the patient crossed over the eye drops (if asymptomatic in one eye), or continued with nedocromil sodium in both eyes (if asymptomatic in both eyes). All patients were examined weekly and ocular surface temperature recorded for a period of 6 weeks. RESULTS: Improvement in the watering, discharge, conjunctival hyperaemia, papillary hypertrophy, and Trantas' dots was noted in both groups, but overall fluorometholone was significantly more effective than nedocromil. Eyes treated with fluorometholone showed a significant decrease in ocular surface temperature compared with nedocromil treated eyes (p = 0.03). CONCLUSIONS: Both nedocromil and fluorometholone were effective in ameliorating the signs and symptoms of vernal keratoconjunctivitis. No adverse effects were noted in the nedocromil group. (+info)Adenovirus strains of subgenus D associated with nosocomial infection as new etiological agents of epidemic keratoconjunctivitis in Japan. (4/234)
Adenovirus strains of a new type were isolated from patients with epidemic keratoconjunctivitis. They were not completely neutralized by any antiserum against adenovirus prototypes. PCR followed by restriction endonuclease analysis demonstrated that they were type 8. PCR followed by sequencing revealed a high homology rate between them and type 9. (+info)Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. (5/234)
PURPOSE: The goal of the present study was to determine the efficacy of topical 0.5% cidofovir twice daily for 7 days on the replication of multiple adenovirus (Ad) serotypes of subgroup C (Ad1, Ad5, Ad6) in the New Zealand rabbit ocular model. METHODS: In duplicate experiments for each serotype, a total of 20 rabbits (Ad5) or 16 rabbits each (Ad1 and Ad6) were inoculated topically in both eyes, with 1.5 X 10(6) pfu/eye of the appropriate virus. Twenty-four hours later, the rabbits in each serotype group were randomly divided into two topical treatment groups: I, 0.5% cidofovir; II, control vehicle. Treatment was twice daily for 7 days. All eyes were cultured for virus on days 0, 1, 3, 4, 5, 7, 9, 11, and 14. RESULTS: Compared to the control, treatment with 0.5% cidofovir reduced the following: mean Ad titer (days 1 to 7) for Ad1 (6.3 +/- 20 x 10(1) versus 2.5 +/- 3.9 X 102 pfu/ml; P < 0.0003), Ad5 (3.4 +/-5.8 x 102 versus 1.6 +/- 2.0 x 10(3) pfu/ml; P < 0.000001), and Ad6 (1.2 +/- 5.1 x 10(2) versus 5.5 +/-14 x 10(2) pfu/ml; P = 0.015); reduced Ad-positive eyes/total for Adl [45/128 (35%) versus 84/128 (66%); P = 0.000002], Ad5 [84/160 (53%) versus 131/152 (86%); P < 0.000001], and Ad6 [36/128 (28%) versus 82/128 (64%); P < 0.000001]: and reduced the duration of Ad shedding forAdl (4.9 +/-1.9 versus 9.3 +/- 3.3 days; P < 0.00007), Ad5 (6.4 +/- 2.8 versus 11.5 +/- 2.3 days; P < 0.0001), and Ad6 (4.4 +/- 2.1 versus 8.4 +/- 2.5 days; P < 0.00004). CONCLUSIONS: Topical 0.5% cidofovir twice daily for 7 days demonstrated significant antiviral activity against multiple adenoviral serotypes (Ad1, Ad5, and Ad6) in the New Zealand rabbit ocular model. These in vivo data expand in vitro studies indicating the efficacy of cidofovir against different adenovirus serotypes and support its use in clinical trials. (+info)Multiplex polymerase chain reaction for diagnosis of viral and chlamydial keratoconjunctivitis. (6/234)
PURPOSE: To develop a multiplex polymerase chain reaction (PCR) for the detection of adenovirus, herpes simplex virus, and Chlamydia trachomatis in conjunctival swabs. METHODS: Oligonucleotide primers for detection of the 3 agents were combined in one reaction and evaluated for optimal performance using control DNAs of adenovirus type 2, herpes simplex virus, and C. trachomatis plasmid. The multiplex PCR was evaluated prospectively against its corresponding uniplex PCRs, virus isolation, Chlamydia Amplicor PCR, and an immunoassay technique (immune dot blot test) in a total of 805 conjunctival swabs from patients with suspected viral and chlamydial keratoconjunctivitis. RESULTS: The multiplex PCR was as sensitive as uniplex PCRs for the detection of the agents in clinical specimens. In the prospective study, 48 of 49 (98%) clinical specimens were positive for adenovirus by the multiplex PCR compared with 26 of 49 (53%) by adenovirus isolation. For herpes simplex virus detection, the multiplex PCR had a sensitivity of 92% (34/37) compared with 94.5% (35/37) by cell culture. The multiplex PCR produced identical results to the Amplicor PCR (21/21; 100%) compared with 71% (15/21) by the immune dot blot test. CONCLUSIONS: With clinical specimens the multiplex PCR was as sensitive as its respective uniplex PCRs but more sensitive than adenovirus isolation and as sensitive as herpes simplex virus isolation or C. trachomatis Amplicor PCR. It has the potential to replace several diagnostic tests with consequent savings in cost. The test also reduces the risk of misdiagnosis by the clinicians. (+info)Role of immunoglobulins in protection against Shigella-induced keratoconjunctives. (7/234)
Various immunoglobulin preparations were tested for their ability to protect guinea pig eyes from infection by a virulent strain of Shigella flexneri. Secretory immunoglobulin A was effective in delaying or preventing keratoconjunctivitis in eight guinea pigs when it was used to precoat the organism, and was also placed in the eye with the inoculum. Neither immunoglobulin G nor immunoglobulin M gave any protection when used in the same way. Protection by secretory immunoglobulin A appeared to be related to the antishigella antibody content of the immunoglobulin since a low-titered preparation gave less protection than a higher-titered one. (+info)Detection of endogenous 12-hydroxyeicosatrienoic acid in human tear film. (8/234)
PURPOSE: Increased production of 12-hydroxyeicosatetraenoic acid [12(R)-HETE] and 12-hydroxyeicosatrienoic acid [12(R)-HETrE] positively correlates with the in vivo progression of ocular surface inflammation in rabbits. Tear film was collected from human subjects with inflamed eyes to determine whether these eicosanoids could be detected from endogenous sources. METHODS: Control and inflamed eyes were assessed and assigned a subjective inflammatory score. Tears were collected and extracted with an internal standard. Single-ion-monitoring gas chromatography-mass spectrometry (SIM-GC-MS) was performed to quantitate endogenous levels of 12-HETE and 12-HETrE. RESULTS: 12-HETrE was detected in the tear film of both control and inflamed eyes, with the mean level being seven times higher in inflamed tears. 12-HETE was not detected in control tears and was detected in only 6 of 38 inflamed-eye tear samples. CONCLUSIONS: The current findings demonstrate that the human eye produces detectable amounts of 12-HETrE, which is released into the tear flow. The increased levels of 12-HETrE associated with ocular surface inflammation suggest that this eicosanoid may contribute to inflammation of the ocular surface in humans. (+info)Keratoconjunctivitis is a medical term that refers to the inflammation of both the cornea (the clear, outer layer at the front of the eye) and the conjunctiva (the mucous membrane that covers the inner surface of the eyelids and the white part of the eye).
The condition can cause symptoms such as redness, pain, sensitivity to light, watery eyes, and a gritty or burning sensation in the eyes. Keratoconjunctivitis can be caused by various factors, including viral or bacterial infections, allergies, or environmental irritants like dust, smoke, or chemical fumes.
Treatment for keratoconjunctivitis depends on the underlying cause of the condition and may include medications such as antibiotics, antivirals, or anti-inflammatory agents to reduce inflammation and relieve symptoms. In some cases, artificial tears or lubricants may also be recommended to help keep the eyes moist and comfortable.
Infectious keratoconjunctivitis (IKC) is a medical condition that refers to an inflammation of both the cornea (kerato-) and the conjunctiva (-conjunctivitis), which are the transparent membranes that cover the front part of the eye. IKC is caused by an infection, most commonly due to viral or bacterial pathogens.
The viral form of IKC is often caused by adenoviruses and can be highly contagious, spreading through respiratory droplets, contaminated surfaces, or direct contact with the infected person's eyes. The symptoms may include redness, watery eyes, sensitivity to light, a gritty or burning sensation in the eyes, and discharge. In some cases, there might be swollen lymph nodes near the ear or neck.
Bacterial IKC can result from various bacterial species, such as Staphylococcus aureus, Streptococcus pneumoniae, or Haemophilus influenzae. The symptoms of bacterial IKC are similar to those of viral IKC but may also include more purulent discharge and potential complications like corneal ulcers or abscesses.
Treatment for infectious keratoconjunctivitis depends on the underlying cause. Viral IKC typically resolves within 1-3 weeks without specific treatment, although cool compresses and artificial tears may help alleviate symptoms. Bacterial IKC may require antibiotic eye drops or ointments to clear the infection and prevent complications. In both cases, good hygiene practices are essential to prevent spreading the infection to others.
Keratoconjunctivitis Sicca, also known as dry eye syndrome, is a condition characterized by decreased quality and/or quantity of tears to lubricate and nourish the eye. This can result in discomfort, visual disturbance, and potentially damage to the ocular surface. It is often associated with inflammation of the conjunctiva and the cornea. The symptoms may include dryness, scratchiness, burning, foreign body sensation, pain, redness, blurred vision, and light sensitivity.
Allergic conjunctivitis is a type of conjunctivitis (inflammation of the conjunctiva, the membrane that covers the white part of the eye and the inner surface of the eyelids) caused by an allergic reaction to substances such as pollen, dust mites, or pet dander. It is often characterized by redness, itching, watering, and swelling of the eyes. In some cases, the eyes may also become sensitive to light. Allergic conjunctivitis is not contagious and can be treated with medications such as antihistamines, decongestants, or mast cell stabilizers.
"Moraxella" is a genus of gram-negative, aerobic bacteria that are commonly found on the mucous membranes of humans and animals. They are non-motile and catalase-positive. Some species of Moraxella can cause infections in humans, such as M. catarrhalis, which is a common cause of respiratory tract infections like bronchitis and otitis media (middle ear infection) in children. Another species, M. nonliquefaciens, can be found on the skin and mucous membranes of humans and animals, but it's not considered to be pathogenic.
It is worth noting that Moraxella genus was previously classified under the name Neisseria, but based on genetic and biochemical evidence, they are now considered separate genera.
Viral conjunctivitis is an inflammation of the conjunctiva, the thin membrane that covers the white part of the eye (sclera) and the inner surface of the eyelids, caused by a viral infection. The condition is often characterized by redness, watering, gritty or burning sensation in the eyes, and a clear, watery discharge. In some cases, it may also cause swelling of the eyelids and light sensitivity.
The most common viruses that can cause conjunctivitis are adenoviruses, which are responsible for about 65-90% of all viral conjunctivitis cases. Other viruses that can cause the condition include herpes simplex virus, varicella-zoster virus (which causes chickenpox and shingles), and picornaviruses.
Viral conjunctivitis is highly contagious and can spread easily through direct contact with infected individuals or contaminated surfaces. It typically affects one eye first and then spreads to the other eye within a few days. The condition usually resolves on its own within 1-2 weeks, although in some cases it may take longer to clear up completely.
There is no specific treatment for viral conjunctivitis, and antibiotics are not effective against viral infections. However, cool compresses and artificial tears can help alleviate symptoms such as discomfort and dryness. It is important to practice good hygiene, such as washing hands frequently and avoiding touching the eyes, to prevent the spread of the virus to others.
The conjunctiva is the mucous membrane that lines the inner surface of the eyelids and covers the front part of the eye, also known as the sclera. It helps to keep the eye moist and protected from irritants. The conjunctiva can become inflamed or infected, leading to conditions such as conjunctivitis (pink eye).
Adenoviruses are a group of viruses that commonly cause respiratory infections such as bronchitis, pneumonia, and fevers in humans. They can also cause conjunctivitis (pink eye), croup, and stomach and intestinal inflammation (gastroenteritis). Adenovirus infections are most common in children, but people of any age can be infected. The viruses spread through the air when an infected person coughs or sneezes, or through contact with contaminated surfaces or objects. There is no specific treatment for adenovirus infections, and most people recover on their own within a week or two. However, some people may develop more severe illness, particularly those with weakened immune systems. Preventive measures include frequent hand washing and avoiding close contact with infected individuals. Some adenoviruses can also cause serious diseases in people with compromised immune systems, such as transplant recipients and people undergoing cancer treatment. There are vaccines available to prevent some types of adenovirus infections in military recruits, who are at higher risk due to close living quarters and stress on the immune system from basic training.
In medical terms, "tears" are a clear, salty liquid that is produced by the tear glands (lacrimal glands) in our eyes. They serve to keep the eyes moist, protect against dust and other foreign particles, and help to provide clear vision by maintaining a smooth surface on the front of the eye. Tears consist of water, oil, and mucus, which help to prevent evaporation and ensure that the tears spread evenly across the surface of the eye. Emotional or reflexive responses, such as crying or yawning, can also stimulate the production of tears.
Adenoviridae infections refer to diseases caused by members of the Adenoviridae family of viruses, which are non-enveloped, double-stranded DNA viruses. These viruses can infect a wide range of hosts, including humans, animals, and birds. In humans, adenovirus infections can cause a variety of symptoms, depending on the specific type of virus and the age and immune status of the infected individual.
Common manifestations of adenovirus infections in humans include:
1. Respiratory illness: Adenoviruses are a common cause of respiratory tract infections, such as bronchitis, pneumonia, and croup. They can also cause conjunctivitis (pink eye) and pharyngoconjunctival fever.
2. Gastrointestinal illness: Some types of adenoviruses can cause diarrhea, vomiting, and abdominal pain, particularly in children and immunocompromised individuals.
3. Genitourinary illness: Adenoviruses have been associated with urinary tract infections, hemorrhagic cystitis, and nephritis.
4. Eye infections: Epidemic keratoconjunctivitis is a severe form of conjunctivitis caused by certain adenovirus types.
5. Central nervous system infections: Adenoviruses have been linked to meningitis, encephalitis, and other neurological disorders, although these are rare.
Transmission of adenoviruses typically occurs through respiratory droplets, contaminated surfaces, or contaminated water. Preventive measures include good hygiene practices, such as handwashing and avoiding close contact with infected individuals. There is no specific treatment for adenovirus infections, but supportive care can help alleviate symptoms. In severe cases or in immunocompromised patients, antiviral therapy may be considered.
The lacrimal apparatus is a complex system in the eye that produces, stores, and drains tears. It consists of several components including:
1. Lacrimal glands: These are located in the upper outer part of the eyelid and produce tears to keep the eye surface moist and protected from external agents.
2. Tear ducts (lacrimal canaliculi): These are small tubes that drain tears from the surface of the eye into the lacrimal sac.
3. Lacrimal sac: This is a small pouch-like structure located in the inner part of the eyelid, which collects tears from the tear ducts and drains them into the nasolacrimal duct.
4. Nasolacrimal duct: This is a tube that runs from the lacrimal sac to the nose and drains tears into the nasal cavity.
The lacrimal apparatus helps maintain the health and comfort of the eye by keeping it lubricated, protecting it from infection, and removing any foreign particles or debris.
Conjunctivitis is an inflammation or infection of the conjunctiva, a thin, clear membrane that covers the inner surface of the eyelids and the outer surface of the eye. The condition can cause redness, itching, burning, tearing, discomfort, and a gritty feeling in the eyes. It can also result in a discharge that can be clear, yellow, or greenish.
Conjunctivitis can have various causes, including bacterial or viral infections, allergies, irritants (such as smoke, chlorine, or contact lens solutions), and underlying medical conditions (like dry eye or autoimmune disorders). Treatment depends on the cause of the condition but may include antibiotics, antihistamines, anti-inflammatory medications, or warm compresses.
It is essential to maintain good hygiene practices, like washing hands frequently and avoiding touching or rubbing the eyes, to prevent spreading conjunctivitis to others. If you suspect you have conjunctivitis, it's recommended that you consult an eye care professional for a proper diagnosis and treatment plan.
Mycoplasma conjunctivae is a species of bacteria that belongs to the class Mollicutes and the genus Mycoplasma. It is known to cause infectious keratoconjunctivitis, an inflammation of the cornea and conjunctiva, in various animals such as sheep, goats, and wild ungulates (hoofed mammals).
This bacterium lacks a cell wall, which makes it resistant to many antibiotics that target cell wall synthesis. It can be transmitted through direct contact with infected animals or contaminated fomites (inanimate objects), making it a significant pathogen in veterinary medicine, particularly in intensive farming settings.
It is important to note that Mycoplasma conjunctivae does not infect humans and is not associated with any human diseases.
Ophthalmic solutions are sterile, single-use or multi-dose preparations in a liquid form that are intended for topical administration to the eye. These solutions can contain various types of medications, such as antibiotics, anti-inflammatory agents, antihistamines, or lubricants, which are used to treat or prevent ocular diseases and conditions.
The pH and osmolarity of ophthalmic solutions are carefully controlled to match the physiological environment of the eye and minimize any potential discomfort or irritation. The solutions may be packaged in various forms, including drops, sprays, or irrigations, depending on the intended use and administration route.
It is important to follow the instructions for use provided by a healthcare professional when administering ophthalmic solutions, as improper use can lead to eye injury or reduced effectiveness of the medication.
Adenoviruses, Human: A group of viruses that commonly cause respiratory illnesses, such as bronchitis, pneumonia, and croup, in humans. They can also cause conjunctivitis (pink eye), cystitis (bladder infection), and gastroenteritis (stomach and intestinal infection).
Human adenoviruses are non-enveloped, double-stranded DNA viruses that belong to the family Adenoviridae. There are more than 50 different types of human adenoviruses, which can be classified into seven species (A-G). Different types of adenoviruses tend to cause specific illnesses, such as respiratory or gastrointestinal infections.
Human adenoviruses are highly contagious and can spread through close personal contact, respiratory droplets, or contaminated surfaces. They can also be transmitted through contaminated water sources. Some people may become carriers of the virus and experience no symptoms but still spread the virus to others.
Most human adenovirus infections are mild and resolve on their own within a few days to a week. However, some types of adenoviruses can cause severe illness, particularly in people with weakened immune systems, such as infants, young children, older adults, and individuals with HIV/AIDS or organ transplants.
There are no specific antiviral treatments for human adenovirus infections, but supportive care, such as hydration, rest, and fever reduction, can help manage symptoms. Preventive measures include practicing good hygiene, such as washing hands frequently, avoiding close contact with sick individuals, and not sharing personal items like towels or utensils.
Dacryocystitis is a medical condition that refers to the inflammation of the lacrimal sac, which is a small sac-like structure located in the inner corner of the eye near the nose. The lacrimal sac is responsible for draining tears from the eye into the nasal cavity.
Dacryocystitis can occur as a result of an infection or obstruction in the tear drainage system, leading to the accumulation of tears and other debris in the lacrimal sac. This can cause symptoms such as redness, swelling, pain, and tenderness in the affected area, as well as discharge from the eye or nose.
In some cases, dacryocystitis may be treated with antibiotics to clear up any infection. In more severe cases, surgery may be required to remove any blockages and improve tear drainage. If left untreated, dacryocystitis can lead to complications such as the formation of an abscess or damage to the eye.
Microsporidia are a group of small, obligate intracellular parasites that belong to the kingdom Fungi. They are characterized by their spore stage, which contains a unique infection apparatus called the polar tube or coiled filament. These spores can infect a wide range of hosts, including humans, animals, and insects.
In humans, Microsporidia can cause chronic diarrhea and other gastrointestinal symptoms, particularly in individuals with weakened immune systems, such as those with HIV/AIDS. They can also infect various other tissues, including the eye, muscle, and kidney, leading to a variety of clinical manifestations.
Microsporidia were once considered to be protozoa but are now classified as fungi based on genetic and biochemical evidence. There are over 1,300 species of Microsporidia, with at least 14 species known to infect humans.
Moraxellaceae is a family of Gram-negative, aerobic or facultatively anaerobic bacteria that are commonly found in the environment and on the mucosal surfaces of humans and animals. Infections caused by Moraxellaceae are relatively rare but can occur, particularly in individuals with weakened immune systems.
Two genera within this family, Moraxella and Acinetobacter, are most commonly associated with human infections. Moraxella catarrhalis is a leading cause of respiratory tract infections such as bronchitis, otitis media (middle ear infection), and sinusitis, particularly in children and the elderly. It can also cause conjunctivitis (pink eye) and pneumonia.
Acinetobacter species, on the other hand, are often found in soil and water and can colonize the skin and mucous membranes of humans without causing harm. However, they can become opportunistic pathogens in hospital settings, causing a range of infections such as pneumonia, bloodstream infections, wound infections, and meningitis, particularly in critically ill or immunocompromised patients.
Infections caused by Moraxellaceae can be treated with antibiotics, but the increasing prevalence of antibiotic-resistant strains is a growing concern. Proper infection control measures, such as hand hygiene and environmental cleaning, are essential to prevent the spread of these infections in healthcare settings.
Blepharitis is a common inflammatory condition that affects the eyelids, specifically the eyelash follicles and the edges of the eyelids (called the "eyelid margins"). It can cause symptoms such as redness, swelling, itching, burning, and a crusty or flaky buildup on the lashes. Blepharitis can be caused by a variety of factors, including bacterial infection, skin disorders like seborrheic dermatitis or rosacea, and meibomian gland dysfunction. It is often a chronic condition that requires ongoing treatment to manage symptoms and prevent recurrence.
Sjögren's syndrome is a chronic autoimmune disorder in which the body's immune system mistakenly attacks its own moisture-producing glands, particularly the tear and salivary glands. This can lead to symptoms such as dry eyes, dry mouth, and dryness in other areas of the body. In some cases, it may also affect other organs, leading to a variety of complications.
There are two types of Sjögren's syndrome: primary and secondary. Primary Sjögren's syndrome occurs when the condition develops on its own, while secondary Sjögren's syndrome occurs when it develops in conjunction with another autoimmune disease, such as rheumatoid arthritis or lupus.
The exact cause of Sjögren's syndrome is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Treatment typically focuses on relieving symptoms and may include artificial tears, saliva substitutes, medications to stimulate saliva production, and immunosuppressive drugs in more severe cases.
Shigella flexneri is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that belongs to the family Enterobacteriaceae. It is one of the four species of the genus Shigella, which are the causative agents of shigellosis, also known as bacillary dysentery.
Shigella flexneri is responsible for causing a significant proportion of shigellosis cases worldwide, particularly in developing countries with poor sanitation and hygiene practices. The bacteria can be transmitted through the fecal-oral route, often via contaminated food or water, and can cause severe gastrointestinal symptoms such as diarrhea, abdominal cramps, fever, and tenesmus (the urgent need to defecate).
The infection can lead to inflammation of the mucous membrane lining the intestines, resulting in the destruction of the epithelial cells and the formation of ulcers. In severe cases, Shigella flexneri can invade the bloodstream and cause systemic infections, which can be life-threatening for young children, the elderly, and immunocompromised individuals.
The diagnosis of Shigella flexneri infection typically involves the detection of the bacteria in stool samples using culture methods or molecular techniques such as PCR. Treatment usually involves antibiotics, although resistance to multiple drugs has been reported in some strains. Preventive measures include good hygiene practices, safe food handling, and access to clean water.
An epidemic is the rapid spread of an infectious disease to a large number of people in a given population within a short period of time. It is typically used to describe situations where the occurrence of a disease is significantly higher than what is normally expected in a certain area or community. Epidemics can be caused by various factors, including pathogens, environmental changes, and human behavior. They can have serious consequences for public health, leading to increased morbidity, mortality, and healthcare costs. To control an epidemic, public health officials often implement measures such as vaccination, quarantine, and education campaigns to prevent further spread of the disease.
Oxytetracycline is a broad-spectrum antibiotic, which is part of the tetracycline class. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and reproduction. Medical definition: "A linear tetra cyclic amide antibiotic derived from Streptomyces rimosus, with a wide range of antibacterial activity against both Gram-positive and Gram-negative organisms. It is used especially in the treatment of rickettsial infections, respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases." (Source: Dorland's Illustrated Medical Dictionary)
"Rupicapra" is not a medical term, but a genus name for a group of wild caprine animals, also known as wild goats. The two living species are the Western Rupicapra (Rupicapra rupicapra) and the Eastern Rupicapra (Rupicapra pyrenaica). They are native to mountainous regions in Europe and Asia.
In a medical context, "rupicapra" may appear in rare cases as part of a scientific name for a disease or condition that is named after the animal, but I couldn't find any specific examples of this usage.
The cornea is the clear, dome-shaped surface at the front of the eye. It plays a crucial role in focusing vision. The cornea protects the eye from harmful particles and microorganisms, and it also serves as a barrier against UV light. Its transparency allows light to pass through and get focused onto the retina. The cornea does not contain blood vessels, so it relies on tears and the fluid inside the eye (aqueous humor) for nutrition and oxygen. Any damage or disease that affects its clarity and shape can significantly impact vision and potentially lead to blindness if left untreated.
Shigella vaccines are immunizations that are developed to protect against Shigella infection, which is caused by the bacterium Shigella spp. These vaccines aim to stimulate the immune system to produce an immune response (the production of antibodies and activation of immune cells) that will provide protection against future Shigella infections.
There are currently no licensed Shigella vaccines available for use, although several candidate vaccines are in various stages of development and clinical trials. These vaccines typically contain inactivated or attenuated (weakened) forms of the bacteria, or specific components of the bacteria that can stimulate an immune response.
Shigella infection can cause a range of symptoms, including diarrhea, fever, abdominal cramps, and tenesmus (the strong, frequent urge to have a bowel movement). In severe cases, it can lead to complications such as dehydration, seizures, and hemolytic-uremic syndrome (HUS), which is a serious condition that can cause kidney failure. Shigella infection is most commonly transmitted through contaminated food or water, or direct contact with an infected person's feces.
Fluorophotometry is a medical diagnostic technique that measures the concentration of fluorescein dye in various tissues, particularly the eye. This technique utilizes a specialized instrument called a fluorophotometer which emits light at a specific wavelength that causes the fluorescein to emit light at a longer wavelength. The intensity of this emitted light is then measured and used to calculate the concentration of fluorescein in the tissue.
Fluorophotometry is often used in ophthalmology to assess the permeability of the blood-retinal barrier, which can be helpful in diagnosing and monitoring conditions such as diabetic retinopathy, age-related macular degeneration, and uveitis. It may also have applications in other medical fields for measuring the concentration of fluorescent markers in various tissues.
Cromolyn sodium is a medication that belongs to a class of drugs known as mast cell stabilizers. It works by preventing the release of certain chemicals from mast cells, which are immune system cells found in various tissues throughout the body, including the skin, lungs, and gastrointestinal tract.
Mast cells play an important role in the body's allergic response. When a person is exposed to an allergen, such as pollen or pet dander, mast cells release chemicals like histamine, which can cause symptoms of an allergic reaction, such as itching, swelling, and inflammation.
Cromolyn sodium is used to prevent asthma attacks, hay fever, and other allergic reactions. It is often prescribed for people who have difficulty controlling their symptoms with other medications, such as inhaled corticosteroids or antihistamines.
The medication is available in various forms, including inhalers, nasal sprays, and eye drops. When used as an inhaler, cromolyn sodium is typically administered four times a day to prevent asthma symptoms. As a nasal spray or eye drop, it is usually used several times a day to prevent allergic rhinitis or conjunctivitis.
While cromolyn sodium can be effective in preventing allergic reactions, it does not provide immediate relief of symptoms. It may take several days or even weeks of regular use before the full benefits of the medication are felt.
Fluorescein is not a medical condition or term, but rather a diagnostic dye used in various medical tests and procedures. Medically, it is referred to as Fluorescein Sodium, a fluorescent compound that absorbs light at one wavelength and emits light at another longer wavelength when excited.
In the field of ophthalmology (eye care), Fluorescein is commonly used in:
1. Fluorescein angiography: A diagnostic test to examine blood flow in the retina and choroid, often used to diagnose and manage conditions like diabetic retinopathy, age-related macular degeneration, and retinal vessel occlusions.
2. Tear film assessment: Fluorescein dye is used to evaluate the quality of tear film and diagnose dry eye syndrome by observing the staining pattern on the cornea.
3. Corneal abrasions/foreign body detection: Fluorescein dye can help identify corneal injuries, such as abrasions or foreign bodies, under a cobalt blue light.
In other medical fields, fluorescein is also used in procedures like:
1. Urinary tract imaging: To detect urinary tract abnormalities and evaluate kidney function.
2. Lymphangiography: A procedure to visualize the lymphatic system.
3. Surgical navigation: In some surgical procedures, fluorescein is used as a marker for better visualization of specific structures or areas.
Cattle diseases are a range of health conditions that affect cattle, which include but are not limited to:
1. Bovine Respiratory Disease (BRD): Also known as "shipping fever," BRD is a common respiratory illness in feedlot cattle that can be caused by several viruses and bacteria.
2. Bovine Viral Diarrhea (BVD): A viral disease that can cause a variety of symptoms, including diarrhea, fever, and reproductive issues.
3. Johne's Disease: A chronic wasting disease caused by the bacterium Mycobacterium avium subspecies paratuberculosis. It primarily affects the intestines and can cause severe diarrhea and weight loss.
4. Digital Dermatitis: Also known as "hairy heel warts," this is a highly contagious skin disease that affects the feet of cattle, causing lameness and decreased productivity.
5. Infectious Bovine Keratoconjunctivitis (IBK): Also known as "pinkeye," IBK is a common and contagious eye infection in cattle that can cause blindness if left untreated.
6. Salmonella: A group of bacteria that can cause severe gastrointestinal illness in cattle, including diarrhea, dehydration, and septicemia.
7. Leptospirosis: A bacterial disease that can cause a wide range of symptoms in cattle, including abortion, stillbirths, and kidney damage.
8. Blackleg: A highly fatal bacterial disease that causes rapid death in young cattle. It is caused by Clostridium chauvoei and vaccination is recommended for prevention.
9. Anthrax: A serious infectious disease caused by the bacterium Bacillus anthracis. Cattle can become infected by ingesting spores found in contaminated soil, feed or water.
10. Foot-and-Mouth Disease (FMD): A highly contagious viral disease that affects cloven-hooved animals, including cattle. It is characterized by fever and blisters on the feet, mouth, and teats. FMD is not a threat to human health but can have serious economic consequences for the livestock industry.
It's important to note that many of these diseases can be prevented or controlled through good management practices, such as vaccination, biosecurity measures, and proper nutrition. Regular veterinary care and monitoring are also crucial for early detection and treatment of any potential health issues in your herd.
Topical administration refers to a route of administering a medication or treatment directly to a specific area of the body, such as the skin, mucous membranes, or eyes. This method allows the drug to be applied directly to the site where it is needed, which can increase its effectiveness and reduce potential side effects compared to systemic administration (taking the medication by mouth or injecting it into a vein or muscle).
Topical medications come in various forms, including creams, ointments, gels, lotions, solutions, sprays, and patches. They may be used to treat localized conditions such as skin infections, rashes, inflammation, or pain, or to deliver medication to the eyes or mucous membranes for local or systemic effects.
When applying topical medications, it is important to follow the instructions carefully to ensure proper absorption and avoid irritation or other adverse reactions. This may include cleaning the area before application, covering the treated area with a dressing, or avoiding exposure to sunlight or water after application, depending on the specific medication and its intended use.
A corneal ulcer is a medical condition that affects the eye, specifically the cornea. It is characterized by an open sore or lesion on the surface of the cornea, which can be caused by various factors such as bacterial or fungal infections, viruses, or injury to the eye.
The cornea is a transparent tissue that covers the front part of the eye and protects it from harmful particles, bacteria, and other foreign substances. When the cornea becomes damaged or infected, it can lead to the development of an ulcer. Symptoms of a corneal ulcer may include pain, redness, tearing, sensitivity to light, blurred vision, and a white spot on the surface of the eye.
Corneal ulcers require prompt medical attention to prevent further damage to the eye and potential loss of vision. Treatment typically involves antibiotics or antifungal medications to eliminate the infection, as well as pain management and measures to protect the eye while it heals. In severe cases, surgery may be necessary to repair the damage to the cornea.
Sulfacetamide is a sulfa drug, an antibiotic that is used to treat various infections caused by bacteria. It works by interfering with the ability of bacteria to produce folic acid, which is necessary for their growth and reproduction. Sulfacetamide is often used to treat skin infections, including acne, rosacea, and seborrheic dermatitis.
In medical terms, sulfacetamide can be defined as a topical antibiotic drug that is chemically related to sulfonamides. It is available in various forms, such as creams, lotions, gels, and solutions, and is usually applied directly to the affected area of the skin.
It's important to note that while sulfacetamide can be effective against many types of bacteria, it may not work for all strains, and some people may be allergic to it. Therefore, it should only be used under the guidance and supervision of a healthcare provider.
I believe there may be some confusion in your question. The term "nurseries" is not typically used as a medical term. However, in a general or colloquial context, a nursery often refers to a place where young children are cared for, such as a daycare center or a room in a home dedicated to a child's needs.
If you intended to ask about "nurseries" in the context of horticulture or botany, they refer to places where plants are propagated and grown, often for commercial purposes.
In the medical field, terms with similar spellings but different meanings include:
1. Neonatal Nurseries - These are specialized units in hospitals that provide care for newborn babies who require advanced medical attention, usually born prematurely or with health issues.
2. Nursing Homes/Nurseries for the Elderly - While not directly related to medical definitions, nursing homes are facilities that provide long-term care and support for elderly individuals who can no longer live independently.
Please clarify if you meant a different term or context, so I can provide a more accurate response.
Lissamine Green Dyes are a type of diagnostic dye used in ophthalmology to assess the health and integrity of the tear film and the corneal surface. These dyes have a green color and are often used in conjunction with other dyes like fluorescein. When applied to the eye, Lissamine Green Dyes selectively stain areas of the eye that have been damaged or disrupted, such as areas of dryness, irritation, or inflammation.
The dye binds to denatured proteins and cellular debris on the surface of the eye, highlighting any abnormalities in the tear film or corneal epithelium. Lissamine Green Dyes can help diagnose conditions such as dry eye syndrome, exposure keratopathy, and corneal abrasions. The dye is generally considered safe for use in diagnostic procedures, but it should be used with caution and according to proper protocols to minimize any potential risks or discomfort to the patient.
Viral eye infections are caused by viruses that invade different parts of the eye, leading to inflammation and irritation. Some common types of viral eye infections include conjunctivitis (pink eye), keratitis, and dendritic ulcers. These infections can cause symptoms such as redness, watering, soreness, sensitivity to light, and discharge. In some cases, viral eye infections can also lead to complications like corneal scarring and vision loss if left untreated. They are often highly contagious and can spread through contact with contaminated surfaces or respiratory droplets. Antiviral medications may be used to treat certain types of viral eye infections, but in many cases, the infection will resolve on its own over time. Preventive measures such as good hygiene and avoiding touching the eyes can help reduce the risk of viral eye infections.
Naphazoline is an imidazole-derived direct-acting sympathomimetic amine, which is primarily used as a decongestant in over-the-counter (OTC) nasal sprays and eye drops. It works by narrowing the blood vessels in the lining of the nose and eyes, providing temporary relief from stuffiness, congestion, and swelling caused by allergies or the common cold.
The medical definition of Naphazoline is:
A decongestant and mydriatic agent with a rapid onset of action; used as an ingredient in various topical ophthalmic and nasal preparations to relieve redness, itching, and swelling associated with allergies or other causes. Naphazoline's therapeutic effect is due to its alpha-adrenergic receptor agonist properties, which cause vasoconstriction of the blood vessels in the affected area.
Common brand names containing Naphazoline include:
* Clear EyesÂź
* NaphconÂź
* Opcon-AÂź
* PrivineÂź
* Vasocon-AÂź
As with any medication, it is essential to follow the recommended dosage and usage guidelines provided by the manufacturer or healthcare professional. Prolonged use of Naphazoline can lead to a rebound effect, where the nasal congestion worsens upon discontinuation of the drug. If you experience any adverse effects or have concerns about using Naphazoline, consult your healthcare provider for advice.
A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.
Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.
Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.
Microsporidiosis is an infection caused by microscopic, single-celled parasites belonging to the phylum Microspora. These parasites are primarily intracellular and can infect various organisms, including humans. Infection typically occurs through ingestion of spores present in contaminated food, water, or soil, or through inhalation of spores. Once inside a host, the spores germinate, releasing the infective sporoplasm that invades host cells and multiplies within them.
In humans, microsporidiosis can cause various symptoms depending on the species involved and the immune status of the host. In immunocompetent individuals, it may present as self-limiting diarrhea or mild gastrointestinal disturbances. However, in immunocompromised patients (e.g., those with HIV/AIDS, organ transplants, or using immunosuppressive medications), microsporidiosis can lead to severe and chronic diarrhea, wasting, and potentially life-threatening complications affecting various organs such as the eyes, kidneys, and respiratory system.
Diagnosis of microsporidiosis typically involves detecting the parasites in stool or tissue samples using specialized staining techniques (e.g., chromotrope stains) or molecular methods (e.g., PCR). Treatment usually includes antiparasitic drugs such as albendazole, which has activity against many microsporidian species. In severe cases or when the infection involves multiple organs, additional supportive care and management of underlying immunodeficiencies may be necessary.
Mycoplasma infections refer to illnesses caused by bacteria belonging to the genus Mycoplasma. These are among the smallest free-living organisms, lacking a cell wall and possessing a unique molecular structure. They can cause various respiratory tract infections (like pneumonia, bronchitis), urogenital infections, and other systemic diseases in humans, animals, and birds.
The most common Mycoplasma species that infect humans include M. pneumoniae, M. genitalium, M. hominis, and Ureaplasma urealyticum. Transmission usually occurs through respiratory droplets or sexual contact. Symptoms can vary widely depending on the site of infection but may include cough, chest pain, difficulty breathing, fatigue, joint pain, rash, and genital discharge or pelvic pain in women. Diagnosis often requires specific laboratory tests due to their unique growth requirements and resistance to many common antibiotics. Treatment typically involves macrolide or fluoroquinolone antibiotics.
Mycoplasma: A type of bacteria that lack a cell wall and are among the smallest organisms capable of self-replication. They can cause various infections in humans, animals, and plants. In humans, they are associated with respiratory tract infections (such as pneumonia), urogenital infections (like pelvic inflammatory disease), and some sexually transmitted diseases. Mycoplasma species are also known to contaminate cell cultures and can interfere with research experiments. Due to their small size and lack of a cell wall, they are resistant to many common antibiotics, making them difficult to treat.
Antazoline is an antihistamine drug that is used primarily for its anti-allergic and analgesic (pain-relieving) effects. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Antazoline is often found in combination with other medications, such as naphazoline, in over-the-counter products used to relieve redness and irritation in the eyes and nose.
The medical definition of Antazoline can be described as:
A first-generation antihistamine drug that exhibits both H1 receptor antagonist and local anesthetic properties. It is primarily used as a topical ophthalmic or nasal preparation to relieve redness, itching, and discomfort associated with allergic conjunctivitis and rhinitis. Antazoline may also be combined with other agents, such as naphazoline, in the treatment of sinus congestion and nasal stuffiness.
The off-label uses of Antazoline include:
* Treatment of vertigo and motion sickness
* As an adjunct to local anesthetics to prolong their duration of action
It is important to note that the use of Antazoline may be associated with certain side effects, such as dizziness, drowsiness, dry mouth, and headache. It should be used with caution in patients with narrow-angle glaucoma, prostatic hypertrophy, or bladder neck obstruction.
Fluorometholone is a type of corticosteroid medication that is often used in eye drops to treat various inflammatory conditions of the eye, such as allergies, uveitis, and keratitis. It works by reducing inflammation and suppressing the activity of the immune system in the eye.
Fluorometholone has a fluorinated molecule, which makes it more lipophilic (fat-soluble) than some other corticosteroids, allowing it to penetrate the eye tissue more effectively. It is available in various strengths and forms, including solutions and ointments, for topical application to the eye.
As with any medication, fluorometholone can have side effects, such as increased pressure inside the eye (glaucoma), cataracts, and delayed healing of wounds. It is important to follow the instructions of your healthcare provider when using this medication and report any unusual symptoms or concerns promptly.
Arcanobacterium is a genus of Gram-positive, rod-shaped bacteria that are facultatively anaerobic and non-spore forming. These bacteria were previously classified as part of the Corynebacterium genus but were reclassified due to genetic differences. They are normal flora in the human respiratory and gastrointestinal tracts, but some species have been associated with human diseases such as endocarditis, bacteremia, and wound infections. The most well-known species is Arcanobacterium haemolyticum, which can cause pharyngitis and skin infections. Proper identification of these bacteria is important for appropriate treatment, as some species may be resistant to certain antibiotics.
Eosinophil granule proteins are a group of biologically active molecules that are stored within the granules of eosinophils, which are types of white blood cells. These proteins include:
1. Eosinophil cationic protein (ECP): A protein with potent ribonuclease activity and the ability to disrupt cell membranes. It is involved in the immune response against parasites and has been implicated in the pathogenesis of several inflammatory diseases, such as asthma and allergies.
2. Eosinophil peroxidase (EPO): An enzyme that generates hypohalous acids, which can cause oxidative damage to cells and tissues. It contributes to the microbicidal activity of eosinophils and has been implicated in the pathogenesis of various inflammatory diseases.
3. Major basic protein (MBP): A highly cationic protein that can disrupt cell membranes, leading to cell lysis. MBP is involved in the immune response against parasites and has been linked to tissue damage in several inflammatory conditions, such as asthma, chronic rhinosinusitis, and eosinophilic esophagitis.
4. Eosinophil-derived neurotoxin (EDN): A protein with ribonuclease activity that can induce histamine release from mast cells and contribute to the inflammatory response. EDN is also involved in the immune response against parasites and has been implicated in the pathogenesis of asthma, allergies, and other inflammatory diseases.
These eosinophil granule proteins are released during eosinophil activation and degranulation, which can occur in response to various stimuli, such as immune complexes, cytokines, and infectious agents. Their release contributes to the inflammatory response and can lead to tissue damage in various diseases.
Bacillary dysentery is a type of dysentery caused by the bacterium Shigella. It is characterized by the inflammation of the intestines, particularly the colon, resulting in diarrhea that may contain blood and mucus. The infection is typically spread through contaminated food or water, or close contact with an infected person. Symptoms usually appear within 1-4 days after exposure and can include abdominal cramps, fever, nausea, vomiting, and tenesmus (the strong, frequent urge to have a bowel movement). In severe cases, bacillary dysentery can lead to dehydration, electrolyte imbalance, and other complications. Treatment typically involves antibiotics to kill the bacteria, as well as fluid replacement to prevent dehydration.
Corneal opacity refers to a condition in which the cornea, the clear front part of the eye, becomes cloudy or opaque. This can occur due to various reasons such as injury, infection, degenerative changes, or inherited disorders. As a result, light is not properly refracted and vision becomes blurred or distorted. In some cases, corneal opacity can lead to complete loss of vision in the affected eye. Treatment options depend on the underlying cause and may include medication, corneal transplantation, or other surgical procedures.
Conjunctival diseases refer to a group of medical conditions that affect the conjunctiva, which is the thin, clear mucous membrane that covers the inner surface of the eyelids and the white part of the eye (known as the sclera). The conjunctiva helps to keep the eye moist and protected from irritants.
Conjunctival diseases can cause a range of symptoms, including redness, itching, burning, discharge, grittiness, and pain. Some common conjunctival diseases include:
1. Conjunctivitis (pink eye): This is an inflammation or infection of the conjunctiva that can be caused by viruses, bacteria, or allergies. Symptoms may include redness, itching, discharge, and watery eyes.
2. Pinguecula: This is a yellowish, raised bump that forms on the conjunctiva, usually near the corner of the eye. It is caused by an overgrowth of connective tissue and may be related to sun exposure or dry eye.
3. Pterygium: This is a fleshy growth that extends from the conjunctiva onto the cornea (the clear front part of the eye). It can cause redness, irritation, and vision problems if it grows large enough to cover the pupil.
4. Allergic conjunctivitis: This is an inflammation of the conjunctiva caused by an allergic reaction to substances such as pollen, dust mites, or pet dander. Symptoms may include redness, itching, watery eyes, and swelling.
5. Chemical conjunctivitis: This is an irritation or inflammation of the conjunctiva caused by exposure to chemicals such as chlorine, smoke, or fumes. Symptoms may include redness, burning, and tearing.
6. Giant papillary conjunctivitis (GPC): This is a type of allergic reaction that occurs in response to the presence of a foreign body in the eye, such as a contact lens. Symptoms may include itching, mucus discharge, and a gritty feeling in the eye.
Treatment for conjunctival diseases depends on the underlying cause. In some cases, over-the-counter medications or home remedies may be sufficient to relieve symptoms. However, more severe cases may require prescription medication or medical intervention. It is important to consult with a healthcare provider if you experience persistent or worsening symptoms of conjunctival disease.
Ocular tuberculosis (OTB) is a form of extrapulmonary tuberculosis (TB), which results from the spread of Mycobacterium tuberculosis complex bacteria outside the lungs. In ocular tuberculosis, these bacteria primarily affect the eye and its surrounding structures.
The most common form of OTB is tubercular uveitis, which involves inflammation of the uveal tract (iris, ciliary body, and choroid). Other forms of OTB include:
* Tubercular conjunctivitis: Inflammation of the conjunctiva, the mucous membrane that covers the front part of the eye and lines the inside of the eyelids.
* Tubercular keratitis: Inflammation of the cornea, the transparent outer layer at the front of the eye.
* Tubercular scleritis: Inflammation of the sclera, the white protective coating of the eye.
* Tubercular episcleritis: Inflammation of the episclera, a thin layer of tissue between the conjunctiva and sclera.
* Tubercular dacryoadenitis: Inflammation of the lacrimal gland, which produces tears.
* Tubercular optic neuritis: Inflammation of the optic nerve, which transmits visual information from the eye to the brain.
Diagnosis of OTB can be challenging due to its varied clinical presentations and the need for laboratory confirmation. A definitive diagnosis typically requires the isolation of Mycobacterium tuberculosis from ocular tissues or fluids, which may involve invasive procedures. In some cases, a presumptive diagnosis might be made based on clinical findings, epidemiological data, and response to anti-tuberculous therapy.
Treatment for OTB usually involves a standard anti-tuberculosis regimen consisting of multiple drugs (isoniazid, rifampin, ethambutol, and pyrazinamide) for at least six months. Corticosteroids or other immunosuppressive agents might be used concomitantly to manage inflammation and prevent tissue damage. Close monitoring is essential to ensure treatment adherence, assess response to therapy, and detect potential side effects.
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a condition characterized by insufficient lubrication and moisture of the eyes. This occurs when the tears produced by the eyes are not sufficient in quantity or quality to keep the eyes moist and comfortable. The medical definition of dry eye syndromes includes the following symptoms:
1. A gritty or sandy sensation in the eyes
2. Burning or stinging sensations
3. Redness and irritation
4. Blurred vision that improves with blinking
5. Light sensitivity
6. A feeling of something foreign in the eye
7. Stringy mucus in or around the eyes
8. Difficulty wearing contact lenses
9. Watery eyes, which may seem contradictory but can be a response to dryness
10. Eye fatigue and discomfort after prolonged screen time or reading
The causes of dry eye syndromes can include aging, hormonal changes, certain medical conditions (such as diabetes, rheumatoid arthritis, lupus, Sjogren's syndrome), medications (antihistamines, decongestants, antidepressants, birth control pills), environmental factors (dry air, wind, smoke, dust), and prolonged screen time or reading.
Treatment for dry eye syndromes depends on the severity of the condition and its underlying causes. It may include artificial tears, lifestyle changes, prescription medications, and in some cases, surgical procedures to improve tear production or drainage.